A landmark cancer drug trial is helping set the stage for moving precision medicine into the mainstream of clinical practice, according to a new study. The study, reported in the Journal of Molecular Diagnostics, validates a procedure used in the drug trial that identifies the unique genetic mutations in a patient’s tumor, which is then used as the basis for selecting targeted drugs for treatment.
The Maryland State Department of Education honored the National Cancer Institute with a 2017 award of excellence in career and technology education during an April 25 ceremony in Baltimore.
This year, the Scientific Library marks the 25th anniversary of its NCI at Frederick scrapbook, the pages of which tell the story of a quarter century of cancer research and engagement with both the Frederick community and the world.
Two Werner H. Kirsten Student Interns were recently named Top Scholars in the 2017 Regeneron Science Talent Search, the nation’s most prestigious science and math competition for high school students.
A study of cervical cancer tumors has revealed a mutation in one third of those tumors, suggesting a new approach in drug production for cervical cancer.